Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Cardiology Interventional Radiology Neurology Optometry Pain Management Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Log In

MIGS Case Studies with Dr. May and Dr. Schweitzer

By: Kristopher A. May, OD, FAAO; Justin Schweitzer, OD, FAAO

Webinar Credits: 0

In this episode, faculty review MIGS cases: an older patient that could no longer be compliance with drops and a pseudophakic glaucoma patient whose disease is progressing.

Expiration Date: Friday, December 30, 2022
Release Date: March 2021

This course features bonus case material. View it here

Learning Objectives


  1. Compare and contrast standalone and cataract MIGS (minimally invasive glaucoma surgery) patients: Patient demographics, surgical procedure, and patient follow-up parameters
  2. Understand the MIGS patient journey: How to identify ideal MIGS patients, educate and set expectations, and manage these patients postop

Accreditation and Designation Statement

There is no credit associated with this course.

Faculty and Disclosures

Christopher May, OD

Coldwater Vision Center

Coldwater, MS



Justin Schweitzer, OD

Vance Thompson Vision

Sioux Falls, SD

It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Kristopher May, OD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, and Sight Sciences. Speaker’s Bureau: Alcon, Bausch + Lomb, and Sight Sciences.

Justin Schweitzer, OD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Bausch + Lomb, Dompe, EyePoint, Horizon, Ocular Therapeutix, and Reichert.  Grant/Research Support: Glaukos. Speaker’s Bureau: Aerie, Alcon, Allergan, Bausch + Lomb, Glaukos, Quidel, Sight Sciences, and Sun Pharmaceuticals. Share/Stockholder: Equinox.

The Evolve Medical Education or The Fundingsland Group staff and planners have no financial relationships with commercial interests.



This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group or Sight Sciences.


Step 1 of 3

  • AgreeNeutralDisagree
    Recognize the importance of early diagnosis and treatment of age-related macular degeneration (AMD) and diabetic macular edema (DME).
    Assess the response of anti-vascular endothelial growth factor (VEGF) intravitreal injections and define “suboptimal responders.”
    Understand the most recent monotherapy and combination therapy clinical study evidence using available therapies for AMD, DME, and retinal vein occlusion (RVO).
    Discuss the outcomes of pivotal studies in AMD, DME, and RVO and how study results may differ from real-world dosing methods.
    Develop individualized treatment plans for patients with retina disorders that use a combination of imaging, treat and extend, or treat and observe.
    Discuss the ocular and systemic effects of anti-VEGF therapies and how to educate patients on appropriate expectations.

Video Resources